A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer Meeting Abstract
| Authors: | Naing, A.; Callahan, M.; Costello, B.; Curti, B.; Hall, E.; Hansen, A.; Long, G.; Joshua, A.; Shankles, B.; Ulge, U.; Ulge, U.; Weickhardt, A. |
| Abstract Title: | A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer |
| Meeting Title: | 36th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2021) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 9 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Nov 10-14 |
| Meeting Location: | Washington, DC |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2021-11-01 |
| Start Page: | A540 |
| Language: | English |
| ACCESSION: | WOS:000774877500489 |
| DOI: | 10.1136/jitc-2021-SITC2021.509 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 509 -- Meeting was also held virtually -- Author Umut Ulge is listed twice on the publication -- Source: Wos |
